Connect with us

Health

Europe Braces for Potentially Severe Flu Season Amid Low Vaccination Rates

Published

on

Public health experts across Europe are warning that this year’s influenza season could be more severe than usual, as vaccination rates remain low and early signs from Asia and the southern hemisphere suggest a stronger wave of infections.

According to the European Centre for Disease Prevention and Control (ECDC), flu activity across the EU and surrounding countries remains “low but increasing,” as expected for mid-October. However, officials fear that a harsh winter and sluggish immunisation rates could create the conditions for widespread outbreaks in the months ahead.

“Europe’s flu season usually runs from November to May, but patterns have become less predictable since the COVID-19 pandemic,” said Colin Russell, professor at Amsterdam University Medical Center and chair of the European Scientific Working Group on Influenza (ESWI). He noted that last year’s flu season was unusually large following a shorter, milder one in 2023-24.

ECDC data shows that 11 European countries are already reporting sporadic flu activity, with the United Kingdom seeing early rises in infections, particularly among children. “It’s the time of year when everything starts,” said Dr Anna Odone, director of the School of Public Health at the University of Pavia in Italy.

Experts say the severity of this year’s flu season will depend on three key factors: how many vulnerable people there are, which flu strains dominate, and the environment. A long, cold winter could encourage indoor gatherings, making it easier for the virus to spread.

Health authorities are closely watching for outbreaks in schools, elderly care facilities, and prisons — areas where people are in close contact — to gauge when the season officially begins. Last year, influenza A (H1 and H3) and influenza B/Victoria were the dominant strains across Europe.

See also  Global Obesity Rates Expected to Soar by 2050, Study Warns

Clues from abroad suggest potential trouble. Australia and New Zealand recently saw a surge in the H3N2 strain toward the end of winter, while Japan declared a nationwide flu epidemic more than a month earlier than usual. Still, experts caution it’s too soon to know which strains will prevail in Europe. “We’re in wait-and-see mode right now,” Russell said.

While influenza rarely causes serious illness in healthy adults, it remains a significant public health concern, causing an estimated 27,600 deaths across the EU annually. Vaccination remains the most effective protection, but uptake has fallen sharply in many countries.

The EU target for flu vaccination coverage is 75%, yet most countries remain below 50%. Only Denmark (76%), Ireland (75%), Portugal (71%), and Sweden (68%) met or approached the target last season.

“Immunisation has social and political connotations,” Odone said. “It’s not easy to reach the high coverage levels needed to control influenza.”

The ECDC urged national governments to rebuild public trust in vaccines, improve access, and emphasise timely vaccination — especially for high-risk groups such as the elderly, pregnant women, children under five, and healthcare workers.

Russell advised people not to wait until flu cases surge: “If you’re not vaccinated yet, now is the time to do it.”

Health

AI Model Surpasses Doctors in Key Medical Decision Tests, Study Finds

Published

on

A new study by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center has found that advanced artificial intelligence systems can outperform human doctors in several medical reasoning tasks, including diagnosis and emergency care decisions.

The research compared physicians with large language models across a range of clinical scenarios. According to the findings, AI systems showed stronger performance in tasks such as identifying likely diagnoses, recommending treatment steps, and making decisions in emergency department settings where information is often limited.

Arjun Manrai, a co-senior author of the study, said the results demonstrate the rapid progress of AI in healthcare. He noted that the model surpassed both earlier systems and physician benchmarks in most tests. At the same time, he cautioned that better performance in controlled settings does not guarantee improved outcomes in real-world care.

The study evaluated OpenAI’s reasoning model, released in 2024, using a mix of published clinical cases and real-world emergency department data. Researchers presented the system with patient scenarios at different stages of care, from initial triage to later admission decisions. At each step, the AI was given only the information available at that point and asked to suggest diagnoses and next actions.

The results showed that the AI consistently outperformed doctors, especially in areas requiring structured reasoning and documentation. The largest gap appeared during the triage stage, when limited information makes decision-making more difficult. As additional data became available, both AI and physicians improved in accuracy, though the AI maintained an edge in many cases.

Peter Brodeur, a co-author of the study, said traditional testing methods such as multiple-choice questions are no longer sufficient to measure progress, as many AI models now achieve near-perfect scores. He added that newer evaluation approaches are needed to track further advances.

See also  Study Finds Intensive Blood Pressure Control Reduces Risk of Heart Attack and Stroke

Despite the promising results, researchers stressed that the use of AI in healthcare must be approached carefully. They warned that while a model may correctly identify a diagnosis, it could also recommend unnecessary tests or interventions that might carry risks for patients.

The study’s authors called for further trials in real clinical environments to better understand how AI tools perform in practice. They also highlighted the need for investment in infrastructure and clear frameworks to support the safe use of such technologies.

The findings come with some limitations, as the analysis focused on a specific version of the AI model, which has since been updated. Researchers said additional studies are needed to compare different systems and explore how doctors and AI can work together effectively in patient care.

Continue Reading

Health

New Study Reveals How Coffee May Help Protect the Body From Ageing

Published

on

A new study has uncovered a key biological mechanism that may explain why coffee has long been linked to healthier ageing and a lower risk of chronic disease.

Researchers at Texas A&M College of Veterinary Medicine & Biomedical Sciences found that compounds in coffee interact with a protein in the body known as NR4A1, a receptor involved in regulating stress responses, inflammation and cellular repair. The findings shed new light on how coffee may help protect the body from age-related decline.

For years, studies have associated regular coffee consumption with a longer life and reduced risk of conditions such as heart disease, cancer and cognitive decline. Until now, however, the biological processes behind those benefits have remained largely unclear.

The research team identified NR4A1 as a critical target for several naturally occurring compounds in coffee, particularly polyphenols and other polyhydroxylated substances. These compounds bind to the receptor and appear to influence how it functions.

NR4A1 acts as what scientists call a nutrient sensor, responding to dietary compounds and helping the body adapt to stress and damage. It plays an important role in controlling inflammation, maintaining energy balance and promoting tissue repair — all essential processes in healthy ageing.

Stephen Safe, one of the study’s lead researchers, said the findings provide a clearer understanding of coffee’s protective effects. He explained that NR4A1 helps limit damage when tissues are under stress, and that its absence can worsen the effects of injury or disease.

Laboratory tests showed that coffee compounds reduced cellular damage and slowed the growth of cancer cells. When researchers removed NR4A1 from the cells, those benefits disappeared, strongly suggesting that the receptor is central to coffee’s protective action.

See also  World Marks 37th World AIDS Day as Funding Cuts Raise Fears of Setbacks in Global Fight Against HIV

The study also highlights that coffee’s health effects are likely driven by more than caffeine alone. Decaffeinated coffee has also been linked to improvements in learning and memory, indicating that other components, including polyphenols, may play a significant role.

Recent research has suggested that moderate consumption of caffeinated coffee may also reduce anxiety, improve attention and vigilance, and lower levels of inflammation.

Scientists caution that while the findings are promising, more research is needed to determine how significant the NR4A1 pathway is in humans and how it interacts with other biological systems.

Still, the discovery offers an important step toward understanding why coffee remains one of the most widely studied beverages in nutrition science. It also reinforces the idea that compounds found in everyday foods and drinks can play a meaningful role in supporting long-term health and resilience as people age.

Continue Reading

Health

Study Finds Rise in 11 Cancers Among Younger Adults in England

Published

on

A major study has found that rates of 11 types of cancer are increasing among younger adults in England, raising fresh concerns among researchers about factors driving the trend.

The study, conducted by the Institute of Cancer Research and Imperial College London, examined cancer diagnoses between 2001 and 2019 in adults aged 20 to 49. It identified rising incidence in a range of cancers, including breast, colorectal, pancreatic and kidney cancers.

The full list includes breast, colorectal, pancreatic, kidney, liver, gallbladder, thyroid, ovarian and endometrial cancers, as well as oral cancer and multiple myeloma, a form of blood cancer.

Researchers noted that for most of these cancers, rates have also increased among older adults, where cancer remains far more common. This suggests that some shared risk factors may be affecting multiple age groups.

Two cancers, however, stood out. Rates of colorectal and ovarian cancer rose only among younger adults, pointing to possible age-specific causes that are not yet fully understood.

Scientists examined a range of established cancer risk factors, including smoking, alcohol consumption, diet, physical activity and body weight. While these factors are known to contribute significantly to cancer risk, they do not appear to fully explain the recent rise in cases among younger people.

In fact, many of these traditional risk factors have either remained stable or improved over recent decades. Smoking rates have declined, alcohol consumption has generally fallen or levelled off, physical inactivity has decreased, and intake of red and processed meat has dropped.

Obesity was the notable exception. Rates of obesity have risen steadily across all adult age groups and remain a significant contributor to cancer risk. Even so, researchers found that obesity alone could not account for the broader increase in cancer diagnoses among younger adults.

See also  Europe Sees Surge in Mosquito-Borne Viruses Amid Hot Summer

This was particularly true for cancers commonly associated with excess body weight, such as bowel, kidney, pancreatic, liver, gallbladder and endometrial cancers. While rising obesity may be playing a role, it does not fully explain the trend.

The findings suggest that other factors may be contributing. Researchers say further investigation is urgently needed into possible causes, including environmental exposures, changes in diet or lifestyle during childhood, and other early-life influences.

They also pointed to the possibility that improved diagnostic tools, increased screening and greater public awareness may be leading to more cases being detected.

Public health experts say the study highlights the need for continued prevention efforts, particularly in tackling smoking and obesity, which remain more common in disadvantaged communities. As researchers work to better understand the causes, the rise in cancer among younger adults is likely to remain an important area of focus for health authorities.

Continue Reading

Trending